Hikma Pharmaceutical | HIK - Actif À Court Terme





Actif À Court Terme Changement Date
Almirall EUR 747.1M 33.12M 2026-06
argenx SE USD 8.07B 1.17B 2026-06
AstraZeneca USD 31.45B 3.48B 2026-09
Autolus Therapeutics Ltd USD 336.09M 32.74M 2026-06
Bayer EUR 39.6B 5.96B 2026-09
Fresenius EUR 12.29B 678M 2026-09
Genmab DKK 2.8B 228M 2026-06
GlaxoSmithKline GBP 17.9B 336M 2026-09
GRIFOLS EUR 5.35B 40M 2026-09
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.77B 393M 2026-06
Orion EUR 1.34B 139.5M 2026-09
Recordati EUR 1.76B 29.78M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
UCB EUR 6.05B 733M 2025-12